-
Pre-Open Stock Movers 01/05: (BPFH) (MRKR) (FUBO) Higher; (EGHT) (FATE) (VRAY) Lower (more...)
-
Fate Therapeutics Announces September Investor Events
-
Fate Therapeutics Announces September Investor Events
-
Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Fate Therapeutics (FATE) Prices 8.6M Share Offering at $17.50/Sh
-
Fate Therapeutics Announces Pricing of Public Offering of Common Stock
-
Fate Therapeutics Announces Pricing of Public Offering of Common Stock
-
Fate Therapeutics (FATE) Plans Offering of Common Stock
-
Fate Therapeutics Announces Proposed Public Offering of Common Stock
-
Fate Therapeutics Announces Proposed Public Offering of Common Stock
-
Fate Therapeutics (FATE) PT Raised to $26 at Citi
-
Citi Assumes Fate Therapeutics (FATE) at Buy
-
CRISPR/Vertex News Bodes Well or Fate Therapeutics (FATE) - Citi
-
Citi Starts Fate Therapeutics (FATE) at Buy
-
Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
Pre-Open Stock Movers 01/27: (CAPN) (FATE) (HA) (BIIB) Higher; (TUP) (X) (BA) (AAPL) Lower (more...)
-
After-Hours Stock Movers 01/26: (FATE) (RPTP) (ETH) Higher; (X) (LCI) (VMW) Lower (more...)